Vedolizumab
1608051
Approved small_molecule terminated
Quick answer
Vedolizumab for Crohn Disease is a Approved program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 4 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Crohn Disease
- Phase
- Approved
- Modality
- small_molecule
- Status
- terminated